OakChart

Clarivate Plc

CLVTTechnology·Information Technology Services·United Kingdom·Small·NYSE·Nov 11 • 9:30 AM ET

2.38-0.01 (-0.42%)
2026-11-11 15:31 CET
Market cap
1,529.37 USD m
Revenue, TTM
2,271.40 USD m
Net income, TTM
-386.50 USD m
Free cash flow, TTM
322.30 USD m
EPS diluted, TTM
-0.60
P/E
-
Compare

Price

CLVT against its 20, 50 and 200-day averages
2050200miss
1.502.002.503.0027.5M54.9MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26CLVTclose 2.3820-day 1.9550-day 1.85200-day 2.202.38

38.5% under 3.87 on 28 Nov 2025. Last 15 sessions, 50.3% high to low

Profile

CLVT
52-week range, 39% of the way up
1.423.87

Clarivate Plc engages in the provision of global information, analytics, and workflow solutions. It operates through the following segments: Academia and Government (A&G), Intellectual Property (IP), and Life Sciences and Healthcare (LS&H). The A&G segment involves the provision of research and analytics, content aggregation, and workflow software solutions using artificial intelligence. The IP segment includes the maintenance, intelligence, and management solutions. The LS&H focuses on solutions for research and development, regulatory and safety, and commercialization. The company was founded in 1864 and is headquartered in London, the United Kingdom.

IndexRUT
Employees12000
IPOOct 29, 2018
Beta1.32
ATR, 14d0.15
Rel volume0.16
Short float14.47%
Insider own47.68%
Inst own62.28%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap1.52B
Enterprise Value5.45B
Income-386.50M
Sales2.27B
Book/sh7.05
Cash/sh0.40
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees12000
IPOOct 29, 2018

Ratios

P/E-
Forward P/E3.48
PEG0.83
P/S0.67
P/B0.34
P/C5.93
P/FCF4.73
EV/EBITDA6.05
EV/Sales2.40
Quick Ratio0.88
Current Ratio0.88
Debt/Eq0.93
LT Debt/Eq0.92
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.60
EPS next Y0.68
EPS next Q0.16
EPS this Y9.36%
EPS next Y-9.41%
EPS next 5Y4.20%
EPS past 3/5Y63.69% 16.31%
Sales past 3/5Y-2.63% 14.38%
EPS Y/Y TTM-5.74%
Sales Y/Y TTM-9.19%
EPS Q/Q-197.88%
Sales Q/Q-22.71%
EarningsNov 03 BMO
EPS/Sales Surpr.18.51% -21.64%

Ownership

Insider Own47.68%
Insider Trans-0.52%
Inst Own62.28%
Inst Trans0.86%
ROA-3.08%
ROE-7.05%
ROIC-4.45%
Gross Margin36.49%
Oper. Margin7.90%
Profit Margin-17.02%
SMA2021.96%
SMA5028.94%
SMA2008.38%
Trades-

Technical

Shs Outstand639.90M
Shs Float334.78M
Short Float14.47%
Short Ratio11.62
Short Interest48.43M
52W High3.87 -38.50%
52W Low1.42 67.61%
Volatility10.66% 8.29%
ATR (14)0.15
RSI (14)75.61
Beta1.32
Rel Volume0.16
Avg Volume4.17M
Volume33,887

Performance

Perf Week12.26%
Perf Month48.75%
Perf Quarter21.43%
Perf Half Y-2.46%
Perf YTD-28.74%
Perf Year-33.52%
Perf 3Y-63.77%
Perf 5Y-89.51%
Perf 10Y-
Recom2.80
Target Price2.65
Prev Close2.39
Price2.38
Change %-0.42%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Oct 30, 2026ResumedMMorgan StanleyUnderweight$1.50-37.0%
Jan 08, 2026DowngradeGGoldmanBuy → Neutral$3.60+51.3%
Dec 17, 2025DowngradeMMorgan StanleyEqual-Weight → Underweight$3+26.1%
Sep 03, 2025InitiatedWWolfe ResearchPeer Perform
Jul 18, 2025InitiatedJJefferiesHold$4.50+89.1%
Jul 18, 2025DowngradeJJefferiesBuy → Hold$4.50+89.1%
Nov 06, 2024DowngradeWWilliam BlairOutperform → Mkt Perform
Dec 15, 2023DowngradeWWells FargoEqual Weight → Underweight$8+236.1%
Oct 16, 2023UpgradeJJefferiesHold → Buy$10 → $8.50+257.1%
Sep 08, 2023DowngradeBBarclaysEqual Weight → Underweight$8 → $7+194.1%

Peers

Mkt cap
TickerCompanyMkt cap
ITGartner Inc11.74B
RELXRELX Plc ADR69.01B
WLYJohn Wiley & Sons Inc2.55B
TRIThomson-Reuters Corp46.22B
FDSFactset Research Systems Inc11.54B
VRSKVerisk Analytics Inc26.17B
IQVIQVIA Holdings Inc45.87B
MORNMorningstar Inc9.20B
SPGIS&P Global Inc136.54B
MSCIMSCI Inc46.22B

Insider trading

8 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JONATHAN M COLLINSOfficerNov 04 '26Proposed Sale2.2584,663190,492Nov 04 04:07 PM
JONATHAN M COLLINSOfficerNov 03 '26Proposed Sale2.0082,552165,352Nov 03 04:17 PM
Cornick Kenneth L.DirectorAug 06 '26Buy1.86650,0001,209,0001,750,000Aug 10 04:45 PM
Cornick Kenneth L.DirectorAug 07 '26Buy1.85250,000462,5002,000,000Aug 10 04:45 PM
Snyder Andrew MilesDirectorAug 03 '26Sale1.942,489,6184,829,8593,856,597Aug 05 04:32 PM
Andrew Miles SnyderDirectorAug 03 '26Proposed Sale1.982,489,6184,929,444Aug 03 07:17 PM
Veinstein BarPresident, A&GDec 01 '25Sale3.74309,9021,159,033848,811Dec 02 05:18 PM
BAR VEINSTEINOfficerDec 01 '25Proposed Sale3.74309,9021,160,273Dec 01 04:34 PM

Held by

AUM
TickerCompanyAUM
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B
IWMiShares Russell 2000 Index FundAUM: 77.38B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
BSVOEA Bridgeway Omni Small-Cap Value ETFAUM: 2.44B
FNDASchwab Fundamental U.S. Small Company ETFAUM: 8.98B
SCHASchwab U.S. Small-Cap ETFAUM: 22.25B
VTWOVanguard Russell 2000 Index ETFAUM: 16.75B

News

latest 14 of 103
  • Clarivate to Present at the RBC Capital Markets Global Technology, Internet, Media and Telecommunications Conference on November 18 (PR Newswire)
  • Clarivate Expands IPOne Platform with Patent and Litigation Data Connectors for Anthropic's Claude AI (InvestorsHub)
  • Clarivate's IPOne Connects Trusted Patent, Trademark and Litigation Intelligence to Claude (PR Newswire)
  • Clarivate Announces Pricing Terms of Offers to Purchase for Cash Certain of its Outstanding Debt Securities (PR Newswire)
  • Clarivate Commences Offers to Purchase for Cash Certain of its Outstanding Debt Securities (PR Newswire)
  • Loading…
  • Clarivate Lands Its Promised Recurring-Growth Inflection, But Trimmed Guidance And A Price-Led ACV Keep The Recovery Small (Earnings Whispers) +25.90%
  • Clarivate Shares Drop Nearly 7% as Q3 Revenue Miss Overshadows Earnings Beat (InvestorsHub)
  • Clarivate Reports Third Quarter 2026 Results, Delivering Clear Path to Value Creation (PR Newswire)
  • Clarivate to Bring Trusted Trademark Data into Microsoft Copilot Through IPOne (PR Newswire)
  • Clarivate Must Show Its Promised Second-Half Recurring Revenue Inflection Is Real (Earnings Whispers)
  • Clarivate Demonstrates Global Demand For AI-native Web Of Science Research Intelligence (PR Newswire) +5.11%
  • Sterne Kessler and Clarivate Announce Partnership to Develop AI-enhanced Patent Workflow Solutions (Business Wire) +8.07%
  • Clarivate Completes Sale of Life Sciences & Healthcare Segment, Advances Strategic Transformation (PR Newswire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-030.2100.177-0.130444.1566.778
2026Q22026-07-290.1900.181-0.420587.3589.739
2026Q12026-04-290.1800.145-0.063585.5569.58
2025Q42026-02-240.2000.1640.005617604.799
2025Q32025-10-290.1800.158-0.042623.1568.348
2025Q22025-07-300.1800.174-0.106621.4589.49
2025Q12025-04-290.1400.116-0.151593.7570.369
2024Q42025-02-190.2100.203-0.273663660.138
2024Q32024-11-060.1900.186-0.091622.2640.819
2024Q22024-08-060.2000.181-0.462650.3651.9410
2024Q12024-05-080.1400.139-0.141621.2614.8510
2023Q42024-02-270.2300.211-1.298683.7684.5910
2023Q32023-11-070.2100.183-0.010647.2631.4511
2023Q22023-08-030.2100.193-0.210668.8673.110
2023Q12023-05-090.1800.1540.036629.1622.649
2022Q42023-03-010.2200.1720.407675.3650.048

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY-59.260--147.14951.17-
2019FY0.5300.520-0.944974.8973.26
2020FY0.6400.568-0.7281,2771,276
2021FY0.7200.698-0.6141,8771,879
2022FY0.8500.804-6.2382,6602,638
2023FY0.8200.804-1.4692,6292,631
2024FY0.7300.726-0.9632,5572,554
2025FY0.6900.658-0.3002,4552,443
2026FY-0.755--2,176
2027FY-0.684--1,997
2028FY-0.781--2,056

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-04605496.76480.04502.8
2026Q4S2026-11-03604517.12494598.16
2026Q4S2026-10-12601562.82498598.16
2026Q4S2026-10-07603562.82498598.16
2026Q4S2026-07-30603578.49506.7598.16
2026Q4S2026-07-29703583.56506.7614
2026Q4S2026-07-14701588.82515614
2026Q4S2026-07-13701589.11515614
2026Q4S2026-07-03704589.11515614
2026Q4S2026-07-02704589.04514.5614
2026Q4S2026-06-27703602.68590.4614
2026Q4S2026-05-10704602.68590.4614
2026Q4S2026-05-01714602.68590.4614
2026Q4S2026-04-29714603.25590.4614

Estimate history

EPS, annual-160.826-147.138-0.944-0.728-0.614-6.238-1.469-0.963-0.299-0.6044
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.091-0.273-0.151-0.106-0.0420.005-0.063-0.42-0.126
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual917.634968.468974.3451254.0471876.8942659.82628.82556.72455.22271.4
Period201720182019202020212022202320242025TTM
Sales, quarterly622.2663593.7621.4623.1617585.5587.3481.6
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual1.6451.646306.874606.33683.139674.409666.1691.4640.7639.9
Period201720182019202020212022202320242025MRQ
Shares, quarterly710.3691.4683.1672.2661.4640.7639.2639.7639.9
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue2,271.402,455.202,556.702,628.802,659.801,876.891,254.05974.35968.47
Cost of Goods Sold Incl. D&A1,442.501,590.801,596.201,614.701,664.501,163.92732.45552.54633.72
Gross Profit828.90864.40960.501,014.10995.30712.98521.60421.80334.74
Selling, General and Administrative Excl. Other649.40686.10727.60739.70729.90668.07523.58475.01383.09
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income179.50178.30232.90274.40265.4044.90-1.98-53.21-48.35
Interest Expense246.40265.40283.40293.70270.30252.49114.39158.37130.81
Unusual Expense290.9086.00555.10954.604,309.0023.05253.6342.3663.74
Net Income Before Taxes-334.90-193.90-553.80-1,012.50-3,989.10-258.15-314.17-248.43-236.51
Income Taxes-2.807.2082.90-101.30-28.9012.30-2.3010.205.65
Consolidated Net Income-332.10-201.10-636.70-911.20-3,960.20-270.45-311.87-258.63-242.16
Net Income From Continuing Operations-332.10-201.10-636.70-911.20-3,960.20-270.45-311.87-258.63-242.16
Net Income-386.50-201.10-668.00-986.60-4,035.60-311.96-311.87-258.63-242.16
EPS (Recurring)-0.29-0.21-0.40-0.47-1.79-0.59-0.31-0.84-120.03
EPS (Basic, Before Extraordinaries)-0.60-0.30-0.96-1.47-5.97-0.49-0.73-0.94-147.14
EPS (Diluted)-0.60-0.30-0.96-1.47-6.24-0.61-0.73-0.94-147.14
EBITDA900.60935.50959.90982.70975.90582.72301.17147.33188.88
Non-Operating Income (Expense)22.90-20.8051.80-38.60324.80-27.5155.845.516.38
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense43.2949.7747.8786.0380.74101.8930.4037.5110.01
Price To Earnings Ratio---41.39-----
Price To Sales Ratio0.470.921.382.372.138.0310.154.720.02
Gross Margin36.4935.2137.5738.5837.4237.9941.5943.2934.56
Operating Margin7.907.269.1110.449.982.39-0.16-5.46-4.99
Net Margin-17.02-8.19-26.13-37.53-151.73-16.62-24.87-26.54-25.00
Shares Outstanding639.90640.70691.40666.10674.41683.14606.33306.871.65
Market Capitalization1,529.371,529.373,608.856,147.935,622.7416,150.8818,002.985,147.87823.69

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue481.60587.30585.50617.00623.10621.40593.70663.00
Cost of Goods Sold Incl. D&A301.30371.20376.10393.90410.00394.50392.40413.70
Gross Profit180.30216.10209.40223.10213.10226.90201.30249.30
Selling, General and Administrative Excl. Other134.80171.40168.10175.10165.90181.10178.40180.80
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income45.5044.7041.3048.0047.2045.8022.9068.50
Interest Expense61.0060.4059.0066.0068.5066.6064.3069.90
Unusual Expense4.30244.0020.2022.4018.509.3024.70229.50
Net Income Before Taxes-20.90-260.60-28.80-24.60-24.50-59.70-85.10-132.20
Income Taxes5.508.0011.40-27.703.8012.3018.8059.60
Consolidated Net Income-26.40-268.60-40.203.10-28.30-72.00-103.90-191.80
Net Income From Continuing Operations-26.40-268.60-40.203.10-28.30-72.00-103.90-191.80
Net Income-80.80-268.60-40.203.10-28.30-72.00-103.90-191.80
EPS (Recurring)-0.12-0.15-0.040.03-0.02-0.10-0.13-0.04
EPS (Basic, Before Extraordinaries)-0.13-0.42-0.060.00-0.04-0.11-0.15-0.27
EPS (Diluted)-0.13-0.42-0.060.00-0.04-0.11-0.15-0.27
EBITDA207.80230.40225.30237.10239.00236.70208.30254.50
Non-Operating Income (Expense)-1.10-0.909.1015.8015.30-29.60-19.0098.70
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense6.0811.9311.5313.7512.6414.62-11.108.61
Price To Sales Ratio0.470.570.660.901.021.171.071.40
Gross Margin37.4436.8035.7636.1634.2036.5133.9137.60
Operating Margin9.457.617.057.787.587.373.8610.33
Net Margin-16.78-45.73-6.870.50-4.54-11.59-17.50-28.93
Shares Outstanding639.90639.70639.20640.70661.40672.20683.10691.40
Market Capitalization1,529.371,380.711,620.972,209.192,574.602,937.272,707.603,608.85

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments329.20295.20370.70356.80587.61269.0176.1425.5877.55
Short Term Receivables821.70798.30908.30872.10906.43737.73333.86331.30317.81
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets159.10151.10183.20166.30143.20320.7783.0851.7348.55
Total Current Assets1,310.001,244.601,462.201,395.201,637.241,327.51493.08408.61443.91
Net Property, Plant & Equipment99.30107.10106.80113.40169.88168.62103.4920.6423.01
Total Investments and Advances1.8014.7017.7047.201.960.000.000.000.00
Intangible Assets9,574.8010,007.8011,030.3012,314.2018,297.2213,622.993,156.683,241.443,471.34
Deferred Tax Assets17.2048.5046.7024.2027.9429.7919.4912.436.82
Other Assets66.3067.5043.1050.7048.7547.9418.6326.5660.03
Total Assets11,069.4011,490.2012,706.8013,944.9020,182.9815,196.853,791.373,709.674,005.11
Short Term Debt Incl. Current Port. of LT Debt119.9020.6024.4026.7062.7564.0631.1360.3445.34
Accounts Payable150.60124.50144.10101.40129.2282.0426.4638.4260.76
Income Tax Payable----28.5445.126.99--
Other Current Liabilities1,298.301,288.401,431.501,431.701,681.461,378.56586.42544.95554.97
Total Current Liabilities1,568.801,433.501,600.001,559.801,901.971,569.77651.00643.71661.07
Long Term Debt4,359.404,571.904,784.305,077.905,550.233,562.221,692.801,930.181,967.73
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities212.10273.30249.60316.10380.06362.2648.5543.2351.79
Other Liabilities86.2072.5080.60178.60424.84421.87150.4341.9538.41
Total Liabilities6,226.506,351.206,714.507,132.408,257.115,916.122,542.772,659.072,719.01
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.001,392.601,392.601,392.620.000.000.000.00
Common Equity4,842.905,139.004,599.705,419.9010,533.259,280.721,248.601,050.611,286.11
Total Shareholders Equity4,842.905,139.005,992.306,812.5011,925.879,280.721,248.601,050.611,286.11
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity4,842.905,139.005,992.306,812.5011,925.879,280.721,248.601,050.611,286.11
Total Liabilities & Stockholders Equity11,069.4011,490.2012,706.8013,944.9020,182.9815,196.853,791.373,709.674,005.11
Book Value Per Share7.567.436.918.0415.4215.314.07638.19781.96
Tangible Book Value Per Share-7.39-7.04-9.65-10.22-11.37-7.16-6.22-1,330.82-1,328.64
Full-Time Employees12,00012,00012,00011,60011,0958,6904,2034,580-
Price to Book Ratio0.340.651.161.201.531.943.79164.74164.74
Return on Assets-1.78-5.26-6.84-23.21-1.53-3.28-6.90-6.28-
Return on Equity-4.03-11.44-14.23-42.27-2.55-5.86-22.50-20.73-
Return on Invested Capital-2.19-6.56-8.46-33.31-1.55-2.43-8.79-8.12-8.11
Quick Ratio0.840.870.910.890.860.850.760.630.67
Current Ratio0.840.870.910.890.860.850.760.630.67

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-386.50-201.10-636.70-911.20-3,960.20-270.45-311.87-258.63-242.16
Depreciation721.10757.20727.00708.30710.50537.82303.15200.54237.22
Other Funds (Non Cash)351.40110.40539.901,085.904,083.101.68249.59171.6020.14
Funds from Operations646.30625.00651.40804.60779.10255.69195.77113.861.10
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-87.403.50-24.90-60.40-271.9068.0867.733.71-27.20
Cash from Operating Activities558.90628.50626.50744.20507.20323.77263.50117.58-26.10
Capital Expenditures-236.60-263.20-289.10-242.50-202.90-118.54-113.69-72.46-45.41
Net Assets From Acquisitions0.000.00-32.00-5.40-24.80-3,930.21-2,919.87-68.42-23.54
Sale of Fixed Assets and Businesses0.000.0084.4010.50285.004.3041.400.0080.88
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities-236.60-263.20-236.70-237.4057.30-4,044.46-2,992.17-140.8811.93
Cash Dividends Paid0.000.00-37.70-75.50-75.40-18.870.000.000.00
Change in Capital Stock-93.10-224.50-200.00-99.50-168.402,119.731,123.391.581.57
Repurchase of Common Pref Stock-93.10-224.50-200.00-100.00-175.00-159.360.000.000.00
Sale of Common Pref Stock0.000.000.000.506.602,279.081,123.391.581.57
Proceedsfrom Stock Options0.000.000.000.005.702,260.52843.740.001.57
Issuance or Reduction of Debt, Net-284.10-109.40-198.10-301.00-498.401,956.351,844.06-406.08-31.71
Change in Long Term Debt-284.10-109.40-198.10-301.00-498.401,956.351,844.06-406.08-31.71
Issuance of Long Term Debt0.10490.600.000.000.002,142.381,981.661,628.0845.00
Reduction of Long Term Debt-284.20-600.00-198.10-301.00-498.40-186.02-137.60-2,034.16-76.71
Net Financing Active Other Cash Flow-5.70-9.20-14.20-20.50-14.90-25.05-40.87479.72-2.47
Other Financing Activities Uses-7.60-10.40-15.60-20.60-14.90-25.05-40.87-202.37-2.47
Cash from Financing Activities-382.90-343.10-450.00-496.50-757.104,032.162,926.5875.22-32.60
Exchange Rate Effect-11.80-15.303.60-38.203.74-5.04-0.97-5.19
Net Change in Cash-61.7034.00-75.5013.90-230.80315.20192.8750.94-51.96
Free Cash Flow322.30365.30337.40501.70304.30205.22155.7947.74-71.51
Preferred Dividends (Cash Flow)-0.00-37.70-75.50-75.40-18.870.000.000.00
Price to Free Cash Flow3.316.1611.7614.5924.7280.8781.7496.37-
Deferred Taxes & Investment Tax Credit--41.5021.20-78.40-54.30-13.36-45.100.36-14.10

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments257.00217.70242.20329.20318.70362.60
Short Term Receivables747.40827.90882.90821.70810.70820.40
Inventories0.000.000.000.000.000.00
Other Current Assets227.90168.60176.00159.10161.70157.20
Total Current Assets1,232.301,214.201,301.101,310.001,291.101,340.20
Net Property, Plant & Equipment83.3088.3093.4099.30102.60109.50
Total Investments and Advances49.2018.2014.101.805.907.10
Intangible Assets8,244.309,079.209,430.309,574.809,715.709,850.90
Deferred Tax Assets19.4017.9016.5017.2049.2051.10
Other Assets739.8068.3071.7066.3063.1062.40
Total Assets10,368.3010,486.1010,927.1011,069.4011,227.6011,421.20
Short Term Debt Incl. Current Port. of LT Debt17.9018.3019.10119.9018.7020.10
Accounts Payable117.20152.90135.70150.60139.70125.70
Other Current Liabilities1,269.401,264.501,387.301,298.301,331.201,333.00
Total Current Liabilities1,404.501,435.701,542.101,568.801,489.601,478.80
Long Term Debt4,166.004,239.204,315.304,359.404,461.104,566.60
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities195.00197.90205.00212.10274.50284.30
Other Liabilities88.4075.8075.9086.2098.6097.40
Total Liabilities5,853.905,948.606,138.306,226.506,323.806,427.10
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity4,514.404,537.504,788.804,842.904,903.804,994.10
Total Shareholders Equity4,514.404,537.504,788.804,842.904,903.804,994.10
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity4,514.404,537.504,788.804,842.904,903.804,994.10
Total Liabilities & Stockholders Equity10,368.3010,486.1010,927.1011,069.4011,227.6011,421.20
Book Value Per Share7.057.097.497.567.417.43
Tangible Book Value Per Share-5.83-7.10-7.26-7.39-7.28-7.23
Full-Time Employees---12,000--
Price to Book Ratio0.340.290.330.450.520.58
Return on Assets-3.08-3.05-1.23-1.78-3.41-3.69
Return on Equity-7.05-7.01-2.80-4.03-7.60-8.18
Return on Invested Capital-0.93-3.06-0.440.03-0.30-0.75
Quick Ratio0.880.850.840.840.870.91
Current Ratio0.880.850.840.840.870.91

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-80.80-268.60-40.203.10-28.30-72.00
Depreciation162.30185.70184.00189.10191.80190.90
Other Funds (Non Cash)83.90243.000.7023.801.6049.80
Funds from Operations166.90148.80144.50186.10158.90163.30
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-1.30-50.10-9.80-26.2022.20-47.00
Cash from Operating Activities165.6098.70134.70159.90181.10116.30
Capital Expenditures-55.40-54.70-55.80-70.70-65.60-66.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-55.40-54.70-55.80-70.70-65.60-66.00
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock0.000.00-18.10-75.00-50.00-49.50
Repurchase of Common Pref Stock0.000.00-18.10-75.00-50.00-49.50
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-73.10-72.60-138.500.10-101.00-8.50
Change in Long Term Debt-73.10-72.60-138.500.10-101.00-8.50
Issuance of Long Term Debt0.000.000.000.10-1.00491.50
Reduction of Long Term Debt-73.10-72.60-138.500.00-100.00-500.00
Net Financing Active Other Cash Flow-0.703.70-5.70-3.00-3.704.10
Other Financing Activities Uses-0.20-0.90-5.70-0.80-1.50-1.50
Cash from Financing Activities-73.80-68.90-162.30-77.90-154.70-53.90
Exchange Rate Effect---3.60-0.80-4.7012.20
Net Change in Cash36.10-21.30-87.0010.50-43.908.60
Free Cash Flow110.2044.0078.9089.20115.5050.30
Price to Free Cash Flow3.314.224.856.068.128.99

Revenue breakdown

Re-occurring Revenues2024: 429.80M 2025: 434.20M
Subscription Revenues2024: 1.63B 2025: 1.61B
Transactional Revenues2024: 500.10M 2025: 415.50M
Asia Pacific2024: 507.50M 2025: 497.40M
EMEA2024: 667.80M 2025: 654.80M
North America2024: 1.38B 2025: 1.30B
Academia & Government Group2024: 1.33B 2025: 1.27B
Intellectual Property Group2024: 811.40M 2025: 799.40M
Life Sciences and Healthcare Group2024: 418.90M 2025: 389.80M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-3014.47%48.4M334.8M4.17M
2026-10-1513.98%46.8M334.7M4.56M
2026-09-3014.41%48.2M334.4M5.47M
2026-09-1514.48%48.4M334.5M6.49M
2026-08-3114.80%49.5M334.5M6.60M
2026-08-1415.26%51.0M334.5M6.72M
2026-07-3115.65%52.8M337.2M6.76M
2026-07-1516.55%55.4M334.5M6.65M
2026-06-3018.46%61.7M334.5M6.10M
2026-06-1515.69%52.5M334.6M5.19M
2026-05-2915.52%52.9M340.6M5.37M
2026-05-1516.52%56.3M340.6M6.67M
2026-04-3016.29%55.4M340.2M7.41M
2026-04-1516.42%56.3M342.5M7.40M
2026-03-3116.22%56.7M349.7M7.30M
2026-03-1315.86%55.5M349.7M7.29M
2026-02-2716.88%59.0M349.7M7.13M
2026-02-1317.51%61.2M349.7M5.96M
2026-01-3013.99%50.5M361.1M5.26M
2026-01-1513.11%47.3M361.1M5.02M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.500.000.000.00-0.000.00---
call1.000.000.000.00-0.000.00---
call1.500.000.000.00-0.000.00---
call2.000.000.000.40-2870.00---
call2.500.000.000.05-4.000.00---
call5.000.000.000.00-0.000.00---
call7.500.000.000.02-1.000.00---
put0.500.000.000.01-1.000.00---
put1.000.000.000.00-0.000.00---
put1.500.000.000.04-21.000.00---
put2.000.000.000.05-40.000.00---
put2.500.000.000.00-0.000.00---
put5.000.000.000.00-0.000.00---
put7.500.000.000.00-0.000.00---

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-108-KCurrent report2026-11-10SEC
2026-11-04144Filing for proposed sale of securities under Rule 144.SEC
2026-11-048-KCurrent report2026-11-04SEC
2026-11-03144Filing for proposed sale of securities under Rule 144.SEC
2026-11-0310-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-038-KCurrent report2026-11-03SEC
2026-10-138-K/A2026-10-06SEC
2026-10-084Statement of changes in beneficial ownership of securities2026-10-06SEC
2026-10-068-KCurrent report2026-10-06SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-10-024Statement of changes in beneficial ownership of securities2026-09-30SEC
2026-09-248-KCurrent report2026-09-24SEC
2026-09-238-KCurrent report2026-09-23SEC
2026-09-178-KCurrent report2026-09-17SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-15SEC
2026-08-174Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-143Initial statement of beneficial ownership of securities2026-08-08SEC
2026-08-104Statement of changes in beneficial ownership of securities2026-08-06SEC
2026-08-054Statement of changes in beneficial ownership of securities2026-08-03SEC
2026-08-03144Filing for proposed sale of securities under Rule 144.SEC
2026-07-298-KCurrent report2026-07-24SEC
2026-07-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-07-298-KCurrent report2026-07-29SEC
2026-07-068-KCurrent report2026-07-06SEC
2026-07-068-KCurrent report2026-07-03SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC
2026-07-024Statement of changes in beneficial ownership of securities2026-06-30SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-081.67M24.83M1
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-12001.16M1
2025-111.14M200

Institutional holders

Manager% owned
Leonard Green & Partners, L.P.18.25%
Exor N.V.10.53%
Clarkston Capital Partners, LLC6.66%
BlackRock, Inc.4.87%
Partners Group Holding AG4.00%
FIL Ltd3.95%
CITADEL ADVISORS LLC2.29%
AMERICAN CENTURY COMPANIES INC2.23%
Invenomic Capital Management LP2.23%
DIMENSIONAL FUND ADVISORS LP2.17%

Funds

Fund% owned
Avantis U.S. Small Cap Value ETF2.35%
Clarkston Partners Fund1.84%
iShares Russell 2000 ETF1.41%
First Trust Technology AlphaDEX Fund1.31%
U.S. SMALL CAP VALUE PORTFOLIO0.99%
Invenomic Fund0.88%
VANGUARD EXTENDED MARKET INDEX FUND0.77%
Fidelity Small Cap Index Fund0.60%
Clarkston Founders Fund0.56%
iShares Russell 2000 Value ETF0.53%

OakChart. CLVT. Cached 15 minutes.